Allopurinol

Active ingredient description

Allopurinol is a xanthine-oxidase inhibitor. Allopurinol and its main metabolite oxipurinol lower the level of uric acid in plasma and urine by inhibition of xanthine oxidase, the enzyme catalyzing the oxidation of hypoxanthine to xanthine and xanthine to uric acid.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Allopurinol
M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AA Preparations inhibiting uric acid production
Discover more medicines within M04AA01

Medicines

Allopurinol is the active ingredient of these drugs:

Drug
Countries

Netherlands

Hong Kong

Hong Kong

Germany

Finland

Hong Kong

Hong Kong

Tunisia

Australia

Poland

Austria

Poland

United States

Cyprus

Finland

Poland

Hong Kong

Germany

Hong Kong

Austria

Brazil

Lithuania Poland

Australia

Hong Kong

Austria Tunisia

Hong Kong

Hong Kong

Ireland

United Kingdom

Austria Singapore

Cyprus

Australia Canada United States

Austria Brazil Cyprus France Hong Kong

Allopurinol is also found within below combination drugs:

DUZALLO

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Structured product labeling (SPL)
US
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

63CZ7GJN5I - ALLOPURINOL

CAS registry number

315-30-0 - allopurinol

SNOMED-CT

387135004 - Allopurinol (substance)